Return on average equity - 5 year average | 15.94 |
Net Income/employee - trailing 12 month | 4,35,011.40 |
Revenue/employee - most recent fiscal year | 42,29,826.00 |
Return on investment - most recent fiscal year | 12.92 |
Return on average assets - most recent fiscal year | 9.75 |
Receivables turnover - most recent fiscal year | 6.01 |
Return on investment - trailing 12 month | 13.32 |
Return on average assets - trailing 12 month | 9.45 |
Inventory turnover - most recent fiscal year | 1.35 |
Inventory turnover - trailing 12 month | 0.94 |
Revenue/employee - trailing 12 month | 42,78,678.00 |
Return on average assets - 5 year average | 10.72 |
Net Income/employee - most recent fiscal year | 4,18,206.50 |
Return on average equity - trailing 12 month | 13.82 |
Receivables turnover - trailing 12 month | 5.43 |
Asset turnover - most recent fiscal year | 0.99 |
Asset turnover - trailing 12 month | 0.93 |
Return on average equity - most recent fiscal year | 13.40 |
Return on investment - 5 year average | 14.25 |
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks